- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02264834
Deambulatory Epidural During the Labour
May 30, 2018 updated by: Dr Madeleine Wilwerth
Comparison of Two Different Peridural During the Labor and Effect of Deambulation
Assess the impact of instrumentation and caesarean related to dyskinesia by reducing the concentration of local anesthetic and therefore the motor block.
Study Overview
Status
Completed
Conditions
Detailed Description
Prospective, randomized and double-blind study performed on primiparous parturient divided into two distinct groups.
Study Type
Interventional
Enrollment (Actual)
164
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bruxelles, Belgium, 1020
- CHUB
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Free written consent.
- ASA I or II,
- Primipara, unique and pregnancy over 36 weeks fetus in cephalic, cervical dilation between 3-6 cm
- VAS> 30 mm
- No contraindications to peridural
Exclusion Criteria:
- Twin pregnancy, less than 36 weeks and 42 weeks
- Fetus in breech position
- Analgesia and sedation within 6h
- Contraindications to peridural
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
Lumbar epidural analgesia during the labour and end up after delivery Levobupivacaine 0.1% + Sufentanil 0.2 µg/mL
|
Levobupivacaine 0.1% + Sufentanil 0.2µg/ml
Other Names:
Introduction of a catheter in lumbar epidural space
Other Names:
|
Experimental: Ambulatory group
Lumbar epidural analgesia during the labour and end up after delivery Levobupivacaine 0.07% + Sufentanil 0.3 µg/mL
|
Introduction of a catheter in lumbar epidural space
Other Names:
Levobupivacaine 0.07% + Sufentanil 0.3µg/ml
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time between peridural application and childbirth
Time Frame: at delivery
|
This will be used to assess labor.
|
at delivery
|
Caesarian
Time Frame: at delivery
|
This will be used to assess labor.
Was a caesarian necessary (yes-no) ?
|
at delivery
|
Instrumentalisation
Time Frame: at delivery
|
This will be used to assess labor.
Was an instrumentalisation (defined as the use of forceps or suction cups) necessary at delivery (yes-no) ?
|
at delivery
|
Apgar score of the baby
Time Frame: at delivery
|
Evaluation of the baby, using the Apgar score.
This will be used to assess labor.
|
at delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bromage score
Time Frame: 1h after the start of the peridural
|
Modified Bromage score (Breen et al) >5 and ability to stand on one leg alternatively.
This will be used to assess perambulation (motricity).
|
1h after the start of the peridural
|
Romberg test
Time Frame: 1h after the start of the peridural
|
Romberg test during 20-30 seconds.
This will be used to assess perambulation (proprioception).
|
1h after the start of the peridural
|
Arterial tension
Time Frame: 1h after the start of the peridural
|
Absence of orthostatic hypotension (i-e less than 20% of the usual arterial tension of the patient).
|
1h after the start of the peridural
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Philippe Vanderlinden, CHUB
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2014
Primary Completion (Actual)
March 20, 2018
Study Completion (Actual)
March 20, 2018
Study Registration Dates
First Submitted
August 1, 2014
First Submitted That Met QC Criteria
October 10, 2014
First Posted (Estimate)
October 15, 2014
Study Record Updates
Last Update Posted (Actual)
May 31, 2018
Last Update Submitted That Met QC Criteria
May 30, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PDB001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on First Pregnancy
-
Cumhuriyet UniversityCompleted
-
University Hospital, Strasbourg, FranceUnknown
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Hilal ÖzbekNot yet recruiting
-
University of California, San FranciscoTerminatedFirst Trimester Pregnancy | Undesired Intrauterine PregnancyUnited States
-
Munzur UniversityRecruitingPregnancy Related | Birth, First | Care | Care Pattern, MaternalTurkey
-
Vrije Universiteit BrusselKU LeuvenCompletedBody Weight | Pregnancy | Health Behavior | First PregnancyBelgium
-
Assistance Publique - Hôpitaux de ParisInstitut Pasteur; Pathogen Discovery LaboratoryRecruitingIncreased Nuchal Translucency in the First Trimester of PregnancyFrance
-
Karolinska InstitutetCompletedFirst Trimester Pregnancy | Surgical Termination of PregnancySweden
-
Eunice Kennedy Shriver National Institute of Child...TerminatedPregnancy | First Trimester BleedingUnited States
Clinical Trials on Levobupivacaine 0.1% + Sufentanil 0.2µg/ml
-
Pontificia Universidad Catolica de ChileUnknown
-
University of PatrasCompletedPostoperative Pain | Morbid Obesity | Postoperative Bowel Function | Postoperative AmbulationGreece
-
University of AarhusCompletedAllergy | Immune Tolerance | Injection Site DiscomfortDenmark
-
Brugmann University HospitalWithdrawn
-
University of GenovaCompleted
-
Fudan UniversityShanghai Jiao Tong University School of MedicineCompletedAnesthesia Complications
-
Ain Shams UniversityCompletedPain After Knee ArthroscopEgypt
-
GlaxoSmithKlineCompleted
-
Gazi UniversityCompletedDrug Effect | Anesthesia | General Surgery | Outpatients | Anorectal Disorder
-
Alcon ResearchCompletedVitreomacular Traction | Vitreomacular AdhesionAustralia